Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19

Título

Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19

Autor

Adnan Shah

Fecha

2020

Materia

cytokines, NLRP3 inflammasome, viroporins, SARS-CoV, COVID-19

Identificador

DOI: 10.3389/fimmu.2020.01021

Fuente

Frontiers in Immunology

Editor

Frontiers Media S.A.

Cobertura

Immunologic diseases. Allergy

Archivos

https://socictopen.socict.org/files/to_import/pdfs/4959965.pdf

Colección

Coronavirus

Citación

Adnan Shah, “Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19,” SOCICT Open, consulta 10 de junio de 2026, https://www.socictopen.socict.org/items/show/2667.

Formatos de Salida

Position: 13865 (24 views)